David P. Crabb

St George's, University of London — United Kingdom

Medicine · Health Sciences

56h-index10.1kcitations465works3.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Glaucoma and retinal disorders(258), Retinal Imaging and Analysis(190), Retinal Diseases and Treatments(156), Ophthalmology and Visual Impairment Studies(70), Corneal surgery and disorders(55)

Publications460 total

Keeping a PROMise: embedding patient voices in ophthalmic outcomes
British Journal of Ophthalmology·2026
Parallelism in neurodegenerative biomarker tests: hidden errors and the risk of misconduct
Critical Reviews in Clinical Laboratory Sciences·2025Open Access
Patient-reported vision impairment in low luminance relates to visual function in age-related macular degeneration: A MACUSTAR study report
Scientific Reports·2025Open Access
Using the Rate of Global and Pointwise Microperimetry Change to Predict Structural Conversion in Intermediate Age-Related Macular Degeneration
Ophthalmology Science·2025Open Access
Six-Year Rate of Visual Field Progression in the Laser in Glaucoma and Ocular Hypertension Trial
Ophthalmology·2025Open Access
Patient-Reported Importance of Functional Benefit in Geographic Atrophy
JAMA Ophthalmology·2025· 1 citedOpen Access
On the Feasibility of Accelerating Glaucoma Clinical Trials Using Portable Perimetry
Ophthalmology Glaucoma·2025· 1 cited
Eyecatcher 3.0 – Validating the Use of “Smart Glasses” as a Low-Cost, Portable Method of Assessing Visual Fields
Translational Vision Science & Technology·2025· 2 citedOpen Access
Implementing patient and public involvement (PPI) in eye research: reflections from developing a research study on Geographic Atrophy treatment acceptability
Research Involvement and Engagement·2025· 2 citedOpen Access
Podcast-driven insights into Charles Bonnet Syndrome: Impact on self-management strategies and communication
Digital Health·2025Open Access
Association of Systemic Calcium Channel Blocker Use with Visual Field Progression in a Large Real-World Cohort from Glaucoma Clinics
Ophthalmology Glaucoma·2025Open Access
Selective Laser Trabeculoplasty After Medical Treatment for Glaucoma or Ocular Hypertension
JAMA Ophthalmology·2025· 5 citedOpen Access
Validating candidate endpoints for intermediate age-related macular degeneration trials in a multi-centre setting—lessons from the MACUSTAR study
Eye·2025· 3 citedOpen Access
The Spectrum of Functional, Structural and Patient-Reported Outcomes in Intermediate Age-Related Macular Degeneration – A MACUSTAR Study Report
Ophthalmologica·2025· 3 citedOpen Access
Relationship Between Intraocular Pressure and the True Rate of Functional and Structural Progression in the United Kingdom Glaucoma Treatment Study
Investigative Ophthalmology & Visual Science·2025· 6 citedOpen Access
Heterogeneous Visual Function Deficits in Intermediate Age-Related Macular Degeneration: A MACUSTAR Report
Ophthalmology Science·2025· 4 citedOpen Access
An overview of quality of life and visual outcomes in AMD
Progress in brain research·2025
Author Response: The Distribution of True Visual Field Progression Rates in Glaucoma
Translational Vision Science & Technology·2024Open Access
Validating and Updating the OHTS-EGPS Model Predicting 5-year Glaucoma Risk among Ocular Hypertension Patients Using Electronic Records
Ophthalmology Glaucoma·2024Open Access
Patient preferences for ocular hypertension monitoring: a discrete choice experiment
BMJ Open Ophthalmology·2024· 1 citedOpen Access
page 1 of 23Next →

Frequent Co-authors

David F. Garway‐Heath(21), Nicholas D. Smith(11), Richard A. Russell(9), Haogang Zhu(8), Catey Bunce(7), Fiona Glen(7), Andrew McNaught(6), Nicholas G. Strouthidis(6), Roger A. Hitchings(4), Gus Gazzard(4), Evgenia Konstantakopoulou(4), Neil Nathwani(4), Robyn Burton(4), Pete R. Jones(4), Luke J. Saunders(4), Adnan Tufail(4), Gerassimos Lascaratos(3), Rupert Bourne(3), David C. Broadway(3), Richard Wormald(3)